EUR/USD 1.15386
-0.490%
Gold 4311.37
-0.852%
Oil 99.213
2.156%
USD/JPY 154.549
0.563%
GBP/USD 1.34836
-0.313%
GBP/JPY 208.391
0.248%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
September 14th news: From September 7th to September 13th, the national logistics operation data is as follows: National railways transported 82.651 million tons of freight, a 6.1% increase compared to the previous period; 58.467 million trucks passed through national expressways, a 2.98% increase compared to the previous period; monitored ports handled 270.168 million tons of cargo, a 0.27% decrease compared to the previous period, and 7.15 million TEUs of containers, a 2.57% increase compared to the previous period; civil aviation handled 122,000 flights (including 5,193 cargo flights, comprising 3,170 international cargo flights and 2,023 domestic cargo flights), a 1.33% decrease compared to the previous period; postal and express delivery collection volume was approximately 4.065 billion pieces, a 0.47% decrease compared to the previous period; delivery volume was approximately 4.068 billion pieces, a 0.51% decrease compared to the previous period.On September 14th, the International Electrotechnical Commission (IEC) released the international standard "Distributed Multi-Energy Systems Part 1: General Principles," led by my country. This standard, drafted by a working group convened by Chinese experts and jointly developed with experts from 10 countries including Switzerland, France, and South Korea, represents another significant achievement for my country in the internationalization of smart energy standards. This international standard systematically defines the connotation and typical architecture of distributed multi-energy systems for the first time, clarifies the standardization development path in the future field of multi-energy integration, and includes typical global engineering application cases, providing a unified reference for the construction of integrated energy projects worldwide.The onshore yuan closed at 6.7071 against the US dollar at 16:30 on September 14, up 25 points from the previous trading day.The Indonesian president has appointed Suhar Nazarra as the new finance minister.According to Metro TV, the Indonesian president will appoint Deputy Finance Minister Suahsir Nazara as the new Finance Minister.

U.S. Restricts Use of J&J's COVID Vaccine Due to Risk of Blood Clots

Charlie Brooks

May 06, 2022 09:38

J2.png


The US Food and Drug Administration said on Thursday that it will restrict adult use of Johnson & Johnson's (NYSE:JNJ) COVID-19 vaccination owing to the danger of a rare blood clotting condition, the latest setback for the injection that has been supplanted by competitors.


The J&J shot, which was cleared for adult use in the United States in February 2021, may be used in situations when permitted or approved COVID-19 vaccinations are unavailable or if an user is averse to receiving the other two doses, the Food and Drug Administration said.


J&J is one of three vaccinations that are now in use in the United States. The remaining two are from Moderna (NASDAQ:MRNA) and Pfizer, respectively (NYSE:PFE).


The vaccine manufacturer said that it has amended the COVID-19 vaccination information sheet for the United States to include a warning regarding the risk of thrombosis associated with thrombocytopenia syndrome (TTS), an uncommon but potentially fatal illness.


In high-income nations, use of the J&J shot has been limited, owing to reports of rare, possibly fatal blood clots, manufacturing difficulties, including an unintentional component mix-up by a contract manufacturer, and doubts about effectiveness.


The manufacturer revised its projection for COVID-19 vaccine sales last month, citing a supply glut.


TTS, which is characterized by blood clots and a low platelet count, has previously been documented in recipients of the J&J vaccination.


The FDA changed the information sheet for the J&J vaccine in January to reflect the risk of immune thrombocytopenia, after months of similar action by the European Union's medicines authority.


The FDA stated Thursday that after conducting a study into reported instances, the risk of TTS justified restricting the use of the single-dose injection.


In December, the US Centers for Disease Control and Prevention suggested that Americans take mRNA doses from Pfizer or Moderna rather than J&J's vaccination owing to the possibility of blood clotting.


According to the CDC, about 18.7 million Americans got a J&J COVID-19 injection, compared to 217.5 million who received the Moderna vaccination and 340.6 million who received the Pfizer shot.

Suggestion